Dogwood Therapeutics Inc DWTX 深 沪
已收盘 08-21 16:00:00 美东时间
2.49
+0.160
+6.87%
华盛通- 最 高2.5757
- 今 开2.31
- 成交量 12.36万股
- 最 低 2.31
- 昨 收 2.33
- 总市值 8464.15万
- 52周最高 9.50
- 市盈率 静 --
- 换手率 0.36%
- 52周最低 1.28
- 委 比 64.97%
- 总股本 3399.26万
- 历史最高 417.75
- 量 比 1.80
- 振 幅 11.40%
- 历史最低 1.28
- 每 手 1
- 风险率 1.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dogwood Therapeutics Q2 EPS $(0.34) Misses $(0.14) Estimate
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.14) by 142.86 percent. This is a 82.91 percent increase over losses of $(1.99) per share from the same period last year.
08-13 20:54
Dogwood Therapeutics Starts New Halneuron Hemotherapy Induced Neuropathic Pain Phase 2b Extension Trial
Dogwood Therapeutics, Inc. (NASDAQ:DWTX) ("Dogwood" or the "Company"), a biopharmaceutical company developing first-in-class, non-opioid medicines to treat pain and neuropathy, today announced commencement of a new
05-18 20:48
Dogwood Therapeutics Q1 EPS $(0.15), Inline
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 98.22 percent increase over losses of $(8.45) per share from the same period last
05-14 20:31
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
美股大行评级 | 美银大幅上调西部数据、希捷科技目标价！宝洁、Baker Hughes、Flagstar Bank、斯伦贝谢等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从48美元升至49美元；Chardan Capital：维持Intellia Therapeutics"买入"评级，目标价从27美元升至30美元
04-28 10:07
